EcoDrugPlus

5-Hydroxytryptamine Receptor 6

Ensembl ID : ENSCSEG00000002597
Gene Symbol: HTR6
3 Cross references
115 Possible Orthologues:

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSCSEG00000002759
Gene Symbol: HTR7
3 Cross references
197 Possible Orthologues:

60s Ribosomal Protein L13a

Ensembl ID : ENSCSEG00000002640
Gene Symbol: LOC103378172
3 Cross references
370 Possible Orthologues:

60s Ribosomal Protein L19

Ensembl ID : ENSCSEG00000009938
Gene Symbol: LOC103392743
3 Cross references
334 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSCSEG00000007614
Gene Symbol: LOC103381476
4 Cross references
321 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSCSEG00000004491
Gene Symbol: LOC103384861
2 Cross references
329 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSCSEG00000019926
Gene Symbol: LOC103391408
3 Cross references
477 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSCSEG00000020556
Gene Symbol: LOC103392522
3 Cross references
338 Possible Orthologues:

60s Ribosomal Protein L35

Ensembl ID : ENSCSEG00000009552
Gene Symbol: LOC103397472
3 Cross references
266 Possible Orthologues:

60s Ribosomal Protein L35-Like

Ensembl ID : ENSCSEG00000011059
Gene Symbol: LOC103397057
3 Cross references
266 Possible Orthologues:

60s Ribosomal Protein L4-B-Like

Ensembl ID : ENSCSEG00000006912
Gene Symbol: LOC103380240
3 Cross references
340 Possible Orthologues:

60s Ribosomal Protein L5

Ensembl ID : ENSCSEG00000019969
Gene Symbol: LOC103397662
3 Cross references
457 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).